Physician profile
John Han
NPI 1578930897
$1,670.65
in general payments reported to CMS, 2019-2025
14 companies · $1,016 in 2025
The $1,016 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $238 · 2022: $219 · 2023: $69.17 · 2024: $127 · 2025: $1,016.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,213.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $694.91 | 2025 | |
| Janssen Pharmaceuticals, INC | $396.45 | 2021-2024 | Xarelto |
| Acera Surgical, INC. | $132.10 | 2025 | Restrata Wound Matrix |
| Ibsa Pharma INC. | $125.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $74.33 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.53 | 2023-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $44.80 | 2025 | Verquvo |
| Gilead Sciences, INC. | $25.70 | 2025 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $23.49 | 2022 | |
| Abbvie INC. | $23.19 | 2025 | |
| Edwards Lifesciences Corporation | $21.87 | 2024 | Sapien 3 Ultra Resilia |
| Aimmune Therapeutics, INC. | $21.46 | 2025 | Zenpep |
| Abbott Laboratories | $20.86 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $18.96 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Han listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.